Loading…

GC Green Cross MS decided to build a new powder-type hemodialysis solution manufacturing line at its Eumseong 2nd plant in South Korea. The project cost increased from 3.7 billion to 4.4 billion won due to automation, with product shipment targeted for the second half of 2024.
“GC녹십자엠에스는 지난 24일 자사 파우더형 혈액투석액 제조라인의 공장을 신설하기로 했다고 25일 밝혔다.”ir.newspim.com
Summarized from public sources; check the original articles before acting on it.